Literature DB >> 1511810

Plasma human amylin levels.

B Leighton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511810     DOI: 10.1007/bf00429106

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  12 in total

1.  In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.

Authors:  S Frontoni; S B Choi; D Banduch; L Rossetti
Journal:  Diabetes       Date:  1991-05       Impact factor: 9.461

2.  Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.

Authors:  S J Koopmans; A D van Mansfeld; H S Jansz; H M Krans; J K Radder; M Frölich; S F de Boer; D K Kreutter; G C Andrews; J A Maassen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

3.  Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Eriksson; M Nakazato; M Miyazato; K Shiomi; S Matsukura; L Groop
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

4.  Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro.

Authors:  B Leighton; G J Cooper
Journal:  Nature       Date:  1988-10-13       Impact factor: 49.962

5.  Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

Authors:  P C Butler; J Chou; W B Carter; Y N Wang; B H Bu; D Chang; J K Chang; R A Rizza
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

6.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus.

Authors:  J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

7.  Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats.

Authors:  B Gedulin; G J Cooper; A A Young
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

8.  Lack of effect of islet amyloid polypeptide in causing insulin resistance in conscious dogs during euglycemic clamp studies.

Authors:  A A Kassir; A K Upadhyay; T J Lim; A R Moossa; J M Olefsky
Journal:  Diabetes       Date:  1991-08       Impact factor: 9.461

9.  Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man.

Authors:  D Bretherton-Watt; S G Gilbey; M A Ghatei; J Beacham; S R Bloom
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

10.  Pharmacological characterization of a receptor for calcitonin gene-related peptide on rat, L6 myocytes.

Authors:  D R Poyner; D P Andrew; D Brown; C Bose; M R Hanley
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.